HIV drug resistance in low-income and middle-income countries

RL Hamers, TFR de Wit, CB Holmes - The Lancet HIV, 2018 - thelancet.com
… for resistance monitoring and prevention. In this Review, we assess contemporary data on
HIV drug resistance … impact and resistance risks of novel ART strategies and knowledge gaps. …

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta …

RK Gupta, J Gregson, N Parkin… - The Lancet infectious …, 2018 - thelancet.com
drug resistance and risk of pretreatment drug resistance in … datasets for pretreatment
drug-resistance data in individuals … , and the International Drug Resistance Workshop for the …

HIV drug resistance: problems and perspectives

PS Pennings - Infectious disease reports, 2013 - mdpi.com
… pneumoniae isolates in our hospital are carbapenem resistant compared to only sporadic
carbapenem resistant isolates prior to 2009.The purpose of this study was to investigate the …

Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis

M Alsan, L Schoemaker, K Eggleston… - The Lancet infectious …, 2015 - thelancet.com
resistance in low-income and middle-income countries, using linear regression to adjust for
environmental factors purported to be predictors of resistance, … that showed resistance to a …

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens

SC Inzaule, RL Hamers, M Doherty… - The Lancet Infectious …, 2019 - thelancet.com
… threat of HIV drug resistance, many low-income and middle-income … the effect of rising
NNRTI resistance and yield improved ART … Second, pre-existing resistance to the co-administered …

Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

A Phillips, V Cambiano, F Nakagawa, T Magubu… - PloS one, 2014 - journals.plos.org
resistance tests for use in low income settings, we assessed cost-effectiveness of drug
resistance … line ART being conditional on NNRTI drug resistance mutations being identified. …

Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index

EY Klein, KK Tseng, S Pant, R Laxminarayan - BMJ global health, 2019 - gh.bmj.com
Drug Resistance Index (DRI)12 to demonstrate the ability to communicate the variations in
antibiotic resistance … of them either lower income or upper-middle-income countries. Because …

Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications

S Mahomed, K Naidoo, N Dookie, N Padayatchi - Tuberculosis, 2017 - Elsevier
… of Mtb influences the probability of drug resistance [6]. Patient factors contributing to de
novo emergence of drug resistance include primary infection with a drug resistant strain, poor …

Antimicrobial resistance: learning lessons from antiparasitic, antibacterial and antimycobacterial drug resistance in low-income settings

CJM Whitty - Transactions of the Royal Society of Tropical …, 2019 - academic.oup.com
resistance and nosocomial transmission. This is compounded by very sparse information on
drug resistance rates and patterns in many low-income settings, … in the same income setting. …

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries

M Ballif, V Nhandu, R Wood… - … of tuberculosis and …, 2014 - ingentaconnect.com
… CONCLUSIONS: Capacity to diagnose and treat drugresistant TB was limited across ART
programs in lowerincomeDrug resistance detection methods Table 1 shows the proximity of …